New targeted treatment promising in breast cancer
 

NEW YORK - An novel investigational chemotherapy regimen targeting both a mutated protein called p53 and tumor blood vessels "has complementary and potent antitumor activity and could define a new strategy for suppression of advanced breast cancers," Dr. Yayun Liang reported at the Department of Defense's annual Era of Hope breast cancer meeting that just wrapped in Baltimore, Maryland.

http://www.reuters.com/article/email...15871220080701

I spoke with my hospital's pathogist recently who was the doctor who signed off of my path report in 2006. I had a normal P53 result. The pathologist told me that the P53 (gene?) tends to be normal in the Her2 positive population.